AU7431796A - Brain-associated inhibitor of tissue-type plasminogen activator - Google Patents

Brain-associated inhibitor of tissue-type plasminogen activator

Info

Publication number
AU7431796A
AU7431796A AU74317/96A AU7431796A AU7431796A AU 7431796 A AU7431796 A AU 7431796A AU 74317/96 A AU74317/96 A AU 74317/96A AU 7431796 A AU7431796 A AU 7431796A AU 7431796 A AU7431796 A AU 7431796A
Authority
AU
Australia
Prior art keywords
brain
tissue
plasminogen activator
type plasminogen
associated inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74317/96A
Inventor
Timothy A Coleman
Patrick J. Dillon
Gregg A Hastings
Daniel A. Lawrence
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU7431796A publication Critical patent/AU7431796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU74317/96A 1996-10-11 1996-10-11 Brain-associated inhibitor of tissue-type plasminogen activator Abandoned AU7431796A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/016484 WO1998016643A1 (en) 1996-10-11 1996-10-11 Brain-associated inhibitor of tissue-type plasminogen activator

Publications (1)

Publication Number Publication Date
AU7431796A true AU7431796A (en) 1998-05-11

Family

ID=22255955

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74317/96A Abandoned AU7431796A (en) 1996-10-11 1996-10-11 Brain-associated inhibitor of tissue-type plasminogen activator

Country Status (5)

Country Link
EP (1) EP0934410A1 (en)
JP (1) JP2002501365A (en)
AU (1) AU7431796A (en)
CA (1) CA2268007A1 (en)
WO (1) WO1998016643A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235529B2 (en) 1996-10-11 2007-06-26 Human Genome Sciences, Inc. Brain-associated inhibitor of tissue-type plasminogen activator
AU2180799A (en) * 1998-02-13 1999-08-30 Peter Sonderegger Neuroserpin
WO2000053793A1 (en) 1999-03-10 2000-09-14 Human Genome Sciences, Inc. Brain-associated inhibitor of tissue-type plasminogen activator
WO2000065349A2 (en) * 1999-04-28 2000-11-02 Cardiogenics Inc. Method for determining plasminogen activator inhibitor
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
GB0217434D0 (en) 2002-07-27 2002-09-04 Royal Vetinary College Biological material
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
GB0315323D0 (en) 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
EP2513146B1 (en) 2009-12-18 2017-05-03 Kancera AB Antibodies against ror1 capable of inducing cell death of cll
GB201020995D0 (en) 2010-12-10 2011-01-26 Bioinvent Int Ab Biological materials and uses thereof
GB201219678D0 (en) 2012-11-01 2012-12-12 Benf Ab Ketone body inhibitors and uses thereof
ES2734374T3 (en) 2013-03-01 2019-12-05 Boehringer Ingelheim Animal Health Usa Inc Quantification of vaccine compositions
GB201320679D0 (en) 2013-11-22 2014-01-08 Univ Nottingham Polypeptides,polynucleotides and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700924A (en) * 1995-06-07 1997-12-23 Incyte Pharmaceuticals, Inc. Serpin derived from human hypothalamus

Also Published As

Publication number Publication date
CA2268007A1 (en) 1998-04-23
EP0934410A1 (en) 1999-08-11
JP2002501365A (en) 2002-01-15
WO1998016643A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
AU1515295A (en) Inhibitors of urokinase plasminogen activator
AU8140898A (en) Inhibitors of beta-lactamases and uses therefor
AU3972697A (en) Inhibitors of cysteine protease
PL323710A1 (en) Reversible inhibitors of cysteinic protease
AU3832895A (en) Thrombin inhibitors
PL314838A1 (en) Inhibitors of bp-iv-serine protease
AU5533094A (en) Enzyme inhibitors
AU1271297A (en) Inhibitor of ceramidase
AU4787596A (en) Thrombin inhibitors
AU7497596A (en) Thrombin inhibitors
AU3941797A (en) Novel thrombin inhibitors
AU3107795A (en) Inhibitors of the benzamidine type
PL328665A1 (en) Inhibitors of serinic protease
AU1877597A (en) Serine protease inhibitors
AU7431796A (en) Brain-associated inhibitor of tissue-type plasminogen activator
AU3124300A (en) Inhibitors of beta-lactamases and uses therefor
AU1808999A (en) Fibrinolytic inhibitor for sealant
AU2190400A (en) Inhibitors of beta-lactamases and uses therefor
AU3951995A (en) Urokinase plasminogen activator fragments
AU2277597A (en) New inhibitors of sh2-mediated processes
AU5955494A (en) Methods and compositions for inhibition of hepatic clearance of tissue-type plasminogen activator
AU9624398A (en) Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors
AU3396697A (en) Thrombin inhibitor
AU3729300A (en) Brain-associated inhibitor of tissue-type plasminogen activator
AU4887296A (en) Trypsin and thrombin inhibitors